Hill-Rom Holdings, Inc. (NYSE:HRC)’s stock price traded up 10.2% during mid-day trading on Wednesday . The company traded as high as $86.55 and last traded at $95.04, 67,040 shares traded hands during mid-day trading. A decline of 93% from the average session volume of 904,006 shares. The stock had previously closed at $86.28.
A number of research analysts have recently issued reports on the company. Needham & Company LLC reiterated a “buy” rating and issued a $131.00 price target on shares of Hill-Rom in a report on Friday, January 24th. Morgan Stanley upgraded Hill-Rom from an “equal” rating to an “equal weight” rating and lifted their price target for the company from $113.00 to $138.00 in a report on Tuesday, December 17th. Finally, Barclays upgraded Hill-Rom from an “equal weight” rating to an “overweight” rating and set a $116.00 price target on the stock in a report on Tuesday, March 17th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Hill-Rom currently has an average rating of “Buy” and a consensus target price of $122.60.
The company has a 50 day moving average of $98.35 and a two-hundred day moving average of $104.92. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.17 and a current ratio of 1.52. The stock has a market capitalization of $5.78 billion, a PE ratio of 46.04, a P/E/G ratio of 1.40 and a beta of 0.95.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Monday, March 23rd will be paid a dividend of $0.22 per share. This represents a $0.88 annualized dividend and a yield of 0.86%. This is an increase from Hill-Rom’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Friday, March 20th. Hill-Rom’s payout ratio is 17.32%.
A number of hedge funds have recently made changes to their positions in the stock. Stifel Financial Corp lifted its position in Hill-Rom by 18.1% during the 4th quarter. Stifel Financial Corp now owns 29,960 shares of the medical technology company’s stock worth $3,405,000 after acquiring an additional 4,599 shares during the period. Parametric Portfolio Associates LLC lifted its position in Hill-Rom by 10.8% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 141,107 shares of the medical technology company’s stock worth $14,849,000 after acquiring an additional 13,708 shares during the period. Select Equity Group L.P. lifted its position in Hill-Rom by 79.9% during the 3rd quarter. Select Equity Group L.P. now owns 2,556,189 shares of the medical technology company’s stock worth $268,988,000 after acquiring an additional 1,135,168 shares during the period. BKD Wealth Advisors LLC lifted its position in Hill-Rom by 3.6% during the 4th quarter. BKD Wealth Advisors LLC now owns 4,390 shares of the medical technology company’s stock worth $498,000 after acquiring an additional 151 shares during the period. Finally, Carroll Financial Associates Inc. acquired a new stake in Hill-Rom during the 4th quarter worth about $52,000. Hedge funds and other institutional investors own 84.52% of the company’s stock.
Hill-Rom Company Profile (NYSE:HRC)
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
See Also: Discover Your Risk Tolerance
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.